Intra-Cellular Therapies research and development expenses for the twelve months ending September 30, 2024 were $0.217B, a 32.7% increase year-over-year.
Intra-Cellular Therapies annual research and development expenses for 2023 were $0.18B, a 33.72% increase from 2022.
Intra-Cellular Therapies annual research and development expenses for 2022 were $0.135B, a 51.63% increase from 2021.
Intra-Cellular Therapies annual research and development expenses for 2021 were $0.089B, a 35.06% increase from 2020.
Intra-Cellular Therapies Research and Development Expenses 2013-2024 | ITCI